HIMS
Hims & Hers Health, Inc.
-0.04 (-0.14%)27.96USD3.7M成交股數6.5B市值–本益比(近四季)2.5股價營收比+38.3%營收年增(近四季)2026-11-09下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 753M+29% | 608M+26% | 599M+49% | 545M+73% | 586M+111% | 481M+112% | 402M+93% | 316M+65% | 278M | 227M | 208M | 191M |
| 營業成本 | 272M | 211M | 157M | 129M | 155M | 112M | 83.7M | 59.0M | 49.1M | 39.4M | 37.8M | 37.3M |
| 毛利 | 481M+12% | 397M+7% | 442M+39% | 416M+62% | 431M+88% | 370M+97% | 318M+87% | 257M+67% | 229M | 187M | 170M | 153M |
| 毛利率 | 63.8% | 65.2% | 73.8% | 76.4% | 73.5% | 76.8% | 79.2% | 81.3% | 82.4% | 82.6% | 81.8% | 80.4% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 165M | 110M | 80.7M | 67.3M | 48.6M | 48.0M | 44.6M | 40.6M | 34.6M | 35.9M | 31.1M | 30.5M |
| 營業利益 | −97.2M-268% | −78.3M-521% | 11.8M-47% | 26.7M+142% | 57.9M+485% | 18.6M-317% | 22.4M-342% | 11.0M-198% | 9.9M | −8.6M | −9.2M | −11.3M |
| 營業利益率 | -12.9% | -12.9% | 2.0% | 4.9% | 9.9% | 3.9% | 5.6% | 3.5% | 3.6% | -3.8% | -4.4% | -5.9% |
| 稅後淨利 | −86.3M-274% | −92.1M-454% | 15.8M-79% | 42.5M+220% | 49.5M+345% | 26.0M-444% | 75.6M-1156% | 13.3M-232% | 11.1M | −7.6M | −7.2M | −10.1M |
| 淨利率 | -11.5% | -15.1% | 2.6% | 7.8% | 8.4% | 5.4% | 18.8% | 4.2% | 4.0% | -3.3% | -3.4% | -5.3% |
| 稀釋 EPS | -0.37-285% | -0.40-500% | 0.06-81% | 0.17+183% | 0.20+300% | 0.10-350% | 0.32-1167% | 0.06-220% | 0.05 | -0.04 | -0.03 | -0.05 |
| 稀釋股數 | 232M | 228M | 249M | 257M | 247M | 237M | 235M | 235M | 229M | 210M | 208M | 207M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 610M | 222M | 346M | 1.1B | 274M | 221M | 166M | 129M | 105M | 58.0M | 65.4M | 48.7M |
| 應收帳款 | 375M | 150M | – | – | – | 6.1M | – | – | – | – | – | – |
| 存貨 | 87.8M | 79.1M | 106M | 142M | 76.1M | 64.4M | 49.1M | 40.6M | 29.8M | 22.0M | 21.4M | 20.7M |
| 總資產 | 3.6B | 2.3B | 2.2B | 1.9B | 892M | 708M | 602M | 481M | 448M | 414M | 390M | 376M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 3.3B | 1.8B | 1.7B | 1.3B | 342M | 231M | 162M | 119M | 104M | 85.3M | 69.8M | 63.6M |
| 股東權益 | 324M | 446M | 581M | 563M | 549M | 477M | 440M | 362M | 344M | 329M | 320M | 313M |
| 負債比 | 91.1% | 80.3% | 74.0% | 70.0% | 38.4% | 32.6% | 26.9% | 24.7% | 23.1% | 20.6% | 17.9% | 16.9% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 89.4M | – | – | 109M+322% | – | – | – | 25.8M | – | – | 9.5M |
| 資本支出 | 32.3M | 36.3M | 69.4M | 50.4M | 59.0M | 26.9M | 5.9M | 6.0M | 14.0M | – | – | – |
| 自由現金流 | – | 53.1M | – | – | 50.1M+323% | – | – | – | 11.8M | – | – | – |
| 折舊攤銷 | – | 22.0M | – | – | 8.3M | – | – | – | 3.0M | – | – | 2.1M |
| 買回庫藏股 | – | – | – | – | 0.00 | – | – | – | 28.1M | – | – | 0.00 |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 8.7% | – | – | 8.5% | – | – | – | 4.3% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
地區2025 年度 · 2.3B
| 美國 | 2.2B | 94.3% | +52.7% |
|---|---|---|---|
| 美國以外 | 134M | 5.7% | +399.2% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 2.3B | +59.0% | 128M | 5.5% | 0.51 | 57.4M |
| FY2024 | 1.5B | +69.3% | 126M | 8.5% | 0.53 | 198M |
| FY2023 | 872M | +65.5% | −23.5M | -2.7% | -0.11 | 47.0M |
| FY2022 | 527M | +93.8% | −65.7M | -12.5% | -0.32 | −33.7M |
| FY2021 | 272M | +82.8% | −108M | -39.6% | -0.58 | – |
| FY2020 | 149M | +80.2% | −18.1M | -12.2% | -0.51 | – |
| FY2019 | 82.6M | – | −72.1M | -87.3% | -2.07 | – |